The Global Leader in Pharmaceutical Brand Naming
The Global Leader in
Pharmaceutical Brand Naming
In the pharmaceutical and biotech industries, naming a drug is more than assigning a label — it’s about creating a globally recognized and regulatory-compliant brand identity. At Brand Institute, we specialize in pharmaceutical name development that ensures your product is distinctive, memorable, and ready for worldwide market approval.
As the top-rated pharmaceutical naming agency, we help you avoid regulatory delays by aligning with FDA, EMA, and global naming standards. Whether you need a proprietary brand name or a nonproprietary INN/USAN, our process delivers strategic, creative, and compliant results.
👉 Schedule your free consultation now!
👉 Schedule your free consultation now!
The Brand Institute Advantage
Industry-Leading Expertise
- Over 30 years providing successful drug naming, medical device naming, and vaccine naming solutions.
- 14 consecutive years leading global approvals in pharmaceutical drug naming, biosimilar naming, and OTC naming.
Regulatory Excellence
- Regulatory subsidiary (Drug Safety Institute) includes former naming officials from FDA, EMA, Health Canada, AMA, and WHO directly involved in every drug naming and biosimilar naming project.
- Team members have co-authored the guidelines for naming drugs and biosimilars while serving at these agencies, ensuring a fully compliant approach to biosimilar naming services.
Proven Success
- Expert creative, trademark, and comprehensive drug name research capabilities.
- Specialized teams dedicated to rx naming, OTC branding, OTC naming, OTC brand strategy, and medical device brand development.
Our Regulatory Advantage
Former Naming Officials
- Benefit from insights of former FDA, EMA, Health Canada, AMA, and WHO leaders in pharmaceutical drug naming and biosimilars naming, actively participating in your project’s strategy.
Fully Compliant Methodology
- Processes continuously updated in alignment with global regulatory guidance for drug name creation and biosimilar naming, directly informed by interactions with regulatory leaders.
Tiered Name Recommendations
- In-depth regulatory-based drug name research enables teams to balance safety, commercial appeal, and regulatory compliance across diverse projects—including biosimilar naming, medical device naming, and OTC product branding.
Our Services
Strategy Services
Unmatched strategy expertise, defining and elevating your brand's impact in the market
Name Development
Diverse team of namers develop hand-crafted names, supported by industry’s most innovative technologies
Trademark Searches.
Experienced team of attorneys and paralegals perform efficient and comprehensive searches
Marketing Research
Online naming and visual identity research surveys, global panel of respondents, results benchmarked to historical norms
Regulatory Services
Industry-leading name safety research, regulatory strategy, reports, rebuttals, consults, and more
Visual Identity
Award-winning designers create dynamic logos, packaging and labelling, collateral material, and websites
Why Choose Brand Institute?
Our people, our proven process, and a track record of exceptional results set us apart from any other drug naming company or OTC product naming company. We’ve successfully partnered with over 1,500 companies on more than 5,000 healthcare-related names, providing unparalleled expertise across every discipline needed to bring your brand to market.
Discover How We Can Help!
Whether you’re launching a new drug or rebranding an existing product, Brand Institute’s pharmaceutical brand name development services are built to support global market success.